These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. Wellbrock C; Marais R J Cell Biol; 2005 Aug; 170(5):703-8. PubMed ID: 16129781 [TBL] [Abstract][Full Text] [Related]
7. C-Raf inhibits MAPK activation and transformation by B-Raf(V600E). Karreth FA; DeNicola GM; Winter SP; Tuveson DA Mol Cell; 2009 Nov; 36(3):477-86. PubMed ID: 19917255 [TBL] [Abstract][Full Text] [Related]
8. High expression of Mcl-1L via the MEK-ERK-phospho-STAT3 (Ser727) pathway protects melanocytes and melanoma from UVB-induced apoptosis. Fukumoto T; Iwasaki T; Okada T; Hashimoto T; Moon Y; Sakaguchi M; Fukami Y; Nishigori C; Oka M Genes Cells; 2016 Feb; 21(2):185-99. PubMed ID: 26791143 [TBL] [Abstract][Full Text] [Related]
9. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells. Yeh CT; Huang WC; Rao YK; Ye M; Lee WH; Wang LS; Tzeng DT; Wu CH; Shieh YS; Huang CY; Chen YJ; Hsiao M; Wu AT; Yang Z; Tzeng YM Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic B-Raf(V600E) induces spindle abnormalities, supernumerary centrosomes, and aneuploidy in human melanocytic cells. Cui Y; Borysova MK; Johnson JO; Guadagno TM Cancer Res; 2010 Jan; 70(2):675-84. PubMed ID: 20068179 [TBL] [Abstract][Full Text] [Related]
11. B-RAF: A contributor to the melanoma phenotype. Heath EM; Kaufman KL; Christopherson RI Int J Biochem Cell Biol; 2011 Jan; 43(1):29-32. PubMed ID: 20883818 [TBL] [Abstract][Full Text] [Related]
12. Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. Gaggioli C; Robert G; Bertolotto C; Bailet O; Abbe P; Spadafora A; Bahadoran P; Ortonne JP; Baron V; Ballotti R; Tartare-Deckert S J Invest Dermatol; 2007 Feb; 127(2):400-10. PubMed ID: 16960555 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells. Zhang L; Shi R; He C; Cheng C; Song B; Cui H; Zhang Y; Zhao Z; Bi Y; Yang X; Miao X; Guo J; Chen X; Wang J; Li Y; Cheng X; Liu J; Cui Y Cancer Lett; 2013 Aug; 337(1):125-32. PubMed ID: 23726842 [TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity of melanoma cell lines with differing B-Raf mutational status to the new oncogenic B-Raf kinase inhibitor UI-152. Kim YK; Ahn SK; Lee M Cancer Lett; 2012 Jul; 320(2):215-24. PubMed ID: 22425959 [TBL] [Abstract][Full Text] [Related]
15. Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development. Cheung M; Sharma A; Madhunapantula SV; Robertson GP Cancer Res; 2008 May; 68(9):3429-39. PubMed ID: 18451171 [TBL] [Abstract][Full Text] [Related]